Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 17.08.2026 11 Alzheimers Dement 1 Ann Neurol 1 Curr Alzheimer Res 1 Exp Gerontol 2 Exp Neurol 11 J Alzheimers Dis 1 J Neuropsychol 1 Lancet 1 Nat Rev Neurol 1 Nature 3 Neurology 1 Neuropsychology 2 PLoS One 1 Rev Neurol (Paris) 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. LIU M, Gong K, Chen Y, Heo G, et al
   A plasma-based protein signature combining NPTXR, ACHE, and p-tau217 predicts progression to symptomatic Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71748.
   PubMed         Abstract available
   
   
2. ALEXOPOULOS H, Louka XP, De Natale ER, Koutroubi K, et al
   Regional astrocyte dysregulation and altered glymphatic-related markers in Alzheimer's disease frontal cortex.
   Alzheimers Dement. 2026;22:e71745.
   PubMed         Abstract available
   
   
3. TONIETTO M, Silvestri E, Belder CRS, Barkhof F, et al
   Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.
   Alzheimers Dement. 2026;22:e71749.
   PubMed         Abstract available
   
   
4. LE GUEN Y, Park J, Pena-Tauber A, Greicius MD, et al
   Proteomic signatures of protected APOE epsilon4 carriers reveal causal pathways associated with delayed Alzheimer's disease onset.
   Alzheimers Dement. 2026;22:e71688.
   PubMed         Abstract available
   
   
5. PASCUAL-LUCAS M, Lacosta AM, Montanes M, Canudas J, et al
   Long-term safety and immunogenicity of ABvac40 active immunotherapy in mild cognitive impairment and very mild Alzheimer's disease: Results from AB1601 phase 2 extension study.
   Alzheimers Dement. 2026;22:e71746.
   PubMed         Abstract available
   
   
6. ZUFIRIA-GERBOLES B, Vereb D, Mijalkov M, Passaretti M, et al
   Vulnerability of locus coeruleus connections to aging and Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71737.
   PubMed         Abstract available
   
   
7. LISGARAS CP, Jacobs T, Figueredo L, Pirraglia E, et al
   CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults.
   Alzheimers Dement. 2026;22:e71720.
   PubMed         Abstract available
   
   
8. BREWER EH, Williams CA, Cary GA, Betarbet R, et al
   Inhibition of Moesin and CD44 in stem cell-derived neurons affects the pathological genetic signature associated with Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71734.
   PubMed         Abstract available
   
   
9. BERISHA DE, Benca RM, Mander BA
   Sleep apnea in REM sleep as an amplifier of vascular contributions to Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71735.
   PubMed         Abstract available
   
   
10. SAIFULLAH K, Ridwan AR, Evia AM, Leurgans SE, et al
    Brain morphometry patterns in the presence of Alzheimer's disease and/or LATE neuropathologic changes.
    Alzheimers Dement. 2026;22:e71719.
    PubMed         Abstract available
    
    
11. PARK JH, Kim B, Al-Amin MM, Tate MD, et al
    Unique transcriptomic alterations in 5XFAD;PS19 mouse model identify glial lipid dysregulation and coordinated microglial-oligodendrocyte responses.
    Alzheimers Dement. 2026;22:e71742.
    PubMed         Abstract available
    
    

    
    Ann Neurol

12. JIANG M, Lan G, Zhu J, Zhang L, et al
    Cross-Sectional and Longitudinal Diagnostic Performance of Plasma p-tau217 and p-tau217/Abeta42 in Alzheimer's Disease.
    Ann Neurol. 2026 Aug 14. doi: 10.1002/ana.78322.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

13. MAGHSOUDLOU F, Esteki A
    Audio?Visual Gamma Stimulation for Alzheimer's Disease: Current Evidence and Future Directions.
    Curr Alzheimer Res. 2026 Jul 30. doi: 10.2174/0115672050478693260720114427.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

14. GUO R, Li D, Zhang X, Liu S, et al
    Alterations in dynamic connectivity in Alzheimer's disease: Network changes and improved multi-stage classification.
    Exp Gerontol. 2026 Aug 13:113285. doi: 10.1016/j.exger.2026.113285.
    PubMed         Abstract available
    
    

    
    Exp Neurol

15. BHAKTA-GUHA D, Guha G
    Alzheimer's disease as a disorder of time-gated clearance: Circadian regulation of Glymphatic function in neurodegeneration.
    Exp Neurol. 2026;406:115959.
    PubMed         Abstract available
    
    
16. LIU Y, Peng L, Li M, Yan W, et al
    Let-7d-5p improves mouse cognitive function by targeting bach1 in Alzheimer's disease.
    Exp Neurol. 2026 Aug 10:115957. doi: 10.1016/j.expneurol.2026.115957.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

17. WELTY S, Bagnell M, Ma F, Herrup K, et al
    Effects of damaged astrocytes on DNA damage and repair in human neurons: Implications for Alzheimer's disease.
    J Alzheimers Dis. 2026 Aug 11:13872877261476036. doi: 10.1177/13872877261476036.
    PubMed         Abstract available
    
    
18. WANG R, Yamasaki T, Mitsudo T, Matsuda Y, et al
    Individual alpha peak frequency tracks Alzheimer's disease progression: A longitudinal pilot study.
    J Alzheimers Dis. 2026 Aug 11:13872877261476331. doi: 10.1177/13872877261476331.
    PubMed         Abstract available
    
    
19. BARKER CCH, Koza LA, Almuhanna L, Trujillo KR, et al
    Lack of effect of repetitive mild traumatic brain injury early in life on the neuropathological and behavioral hallmarks of Alzheimer's disease in 3xTg-AD mice.
    J Alzheimers Dis. 2026 Aug 12:13872877261476274. doi: 10.1177/13872877261476274.
    PubMed         Abstract available
    
    
20. LU YT, Guo ZM, Liu MY, Ji CH, et al
    Correlation analysis between complement proteins and Alzheimer's disease.
    J Alzheimers Dis. 2026 Aug 12:13872877261475358. doi: 10.1177/13872877261475358.
    PubMed         Abstract available
    
    
21. YUAN R, Liao G, Su S, Shan J, et al
    Identification of B-cell senescence-related key genes and mechanisms in Alzheimer's disease through transcriptomic sequencing combined with Mendelian randomization analysis and experimental verification.
    J Alzheimers Dis. 2026 Aug 12:13872877261477008. doi: 10.1177/13872877261477008.
    PubMed         Abstract available
    
    
22. FERREIRA LK, Westman E, Wahlund LO, Mohanty R, et al
    Progression from mild cognitive impairment to dementia in Alzheimer's disease: Whole cortex voxelwise functional connectivity analysis with multivariate distance matrix regression.
    J Alzheimers Dis. 2026 Aug 12:13872877261477016. doi: 10.1177/13872877261477016.
    PubMed         Abstract available
    
    
23. MANDAL PK, Perry G, Maroon JC, Corby P, et al
    Bypassing the bottleneck: Gamma-glutamylcysteine supplementation for brain glutathione enrichment in Alzheimer's disease.
    J Alzheimers Dis. 2026 Aug 13:13872877261474009. doi: 10.1177/13872877261474009.
    PubMed         Abstract available
    
    
24. ZHANG QN, Wu W, Zhou YM, Yu LK, et al
    Decreased cerebrospinal fluid NDRG2 is associated with non-Alzheimer's disease derived mild cognitive impairment.
    J Alzheimers Dis. 2026 Aug 13:13872877261477113. doi: 10.1177/13872877261477113.
    PubMed         Abstract available
    
    
25. LI B, Han J, Yang M, Yang W, et al
    Associations of television viewing, computer use, and Alzheimer's disease among United States adults: A cross-sectional study of NHANES.
    J Alzheimers Dis. 2026 Aug 13:13872877261476960. doi: 10.1177/13872877261476960.
    PubMed         Abstract available
    
    
26. EDEMA M, Popuri K, Lee H, Wang L, et al
    Development and validation of an amyloid PET dementia of the Alzheimer's type (DAT) score.
    J Alzheimers Dis. 2026 Aug 13:13872877261476273. doi: 10.1177/13872877261476273.
    PubMed         Abstract available
    
    
27. JIANG P, Peng S, Huang Y, Wang L, et al
    Evidence from European ancestry genome-wide association studies and a case-control study suggests several selenoproteins are linked to a decreased risk of Alzheimer's disease.
    J Alzheimers Dis. 2026 Aug 13:13872877261476713. doi: 10.1177/13872877261476713.
    PubMed         Abstract available
    
    

    
    J Neuropsychol

28. LIU B
    Temporal dissociation of semantic degradation and interference in Alzheimer's disease: Evidence from Chinese character processing.
    J Neuropsychol. 2026 Aug 11. doi: 10.1111/jnp.70071.
    PubMed         Abstract available
    
    

    
    Lancet

29. KOYCHEV I, Holman RR
    Semaglutide treatment fails but might prevent Alzheimer's disease.
    Lancet. 2026;408:602-603.
    PubMed        
    
    

    
    Nat Rev Neurol

30. FYFE I
    Circular RNAs outperform established Alzheimer disease biomarkers.
    Nat Rev Neurol. 2026 Aug 11. doi: 10.1038/s41582-026-01259.
    PubMed        
    
    

    
    Nature

31. DOLGIN E
    A controversial Alzheimer's surgery is said to reverse symptoms - here's what scientists know.
    Nature. 2026;656:286-289.
    PubMed        
    
    

    
    Neurology

32. HAZAN J, Salemme S, Liu KY, Howard R, et al
    Blood-Based Biomarkers for Alzheimer Disease in Primary Care: The Gap Between Biology and Clinical Utility.
    Neurology. 2026;107:e218403.
    PubMed         Abstract available
    
    
33. BRUNO J, Shaw JS, Hosseini SMH
    Association Between Menopausal Hormone Therapy and Alzheimer Disease Neuropathology.
    Neurology. 2026;107:e218413.
    PubMed         Abstract available
    
    
34. SALEMME S
    Menopausal Hormone Therapy and Alzheimer Disease: When, Which, and for Whom?
    Neurology. 2026;107:e218503.
    PubMed        
    
    

    
    Neuropsychology

35. SERVAIS A, Frick A, Meyer F, Bastin C, et al
    Lifetime familiarity and episodic familiarity: The role of the transentorhinal cortex in aging.
    Neuropsychology. 2026;40:593-617.
    PubMed         Abstract available
    
    

    
    PLoS One

36. MAJUMDER R, Datta P, Moolayadukkam S, Puri IK, et al
    Repurposing Alzheimer's and ovarian cancer drugs as sonosensitizers for glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new approach methodology (NAM).
    PLoS One. 2026;21:e0354981.
    PubMed         Abstract available
    
    
37. ZHANG H, Chen W, Yuan S, Ding S, et al
    Unraveling the molecular Nexus of Alzheimer's Disease and HIV encephalitis: The role of cellular senescence and transcriptional regulation.
    PLoS One. 2026;21:e0355548.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

38. LAUNAY A, Baudouin A, Gonthier C, Brachet M, et al
    Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.
    Rev Neurol (Paris). 2026;182:621-631.
    PubMed         Abstract available
    
    

    
    Science

39. REARDON S
    Tau can wreak havoc in brain cells' energy factories.
    Science. 2026;393:651.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum